Journée Scientifique 2023
32nd ARTP Annual Meeting - 22 November 2023
Palais des Congrès de Paris - 2 place de la Porte Maillot - 75017 Paris
Téléchargez le plan d'accès au Palais des CongrèsTéléchargez le bulletin d'inscription
Téléchargez les instructions pour Poster
Téléchargez le programme de la Journée
Téléchargez l'Abstract Book de la Journée
8:15 a.m.
Registration (3rd floor)
8:55 a.m.
Welcome
Alexandre de la Taille, ARTP President
9:00 a.m
Session I : ARTP 2021/ESUR 2022 Laureates
Chairs :
Benoît Miotto (Institut Cochin, Paris)
'Molecular and prognostic study of the transcription factor ZBTB38 in metastatic progression and treatment resistance in prostate cancer
Gilles Laverny (IGBMC, Strasbourg)
'Role of HIF1A in plasticity of prostatic intraepithelial neoplasia'
Michel Kahi (Inserm U1065, C3M, Nice)
'Inhibition of hypusination reprograms prostate cancer cell metabolism and decreases aggressiveness'
Andrew Hartley (University of Glasgow, Scotland)
'Loss of ARID1A drives aggressive prostate cancer through aberrant cell cycle signalling'
-
10:00 a.m
Coffee Break & Visit of Exhibition Booths
-
-
10:20 a.m
Session II : Signaling and Targeted Therapies in Prostate Cancer
Chairs :
Lukas Kenner (University of Vienna, Austria)
'The STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway'
Guilhem Roubaud (Institut Bergonié, Bordeaux)
'Advanced prostate cancer and alterations in HRR pathway: from bench to bedside'
Bram de Laere (Ghent University, Belgium & Karolinska Institutet,Stockholm, Sweden)
'How comprehensive genomic profiling can guide precision prostate cancer oncology'
12:00 p.m
Lunch
1:15 p.m
Session III : Clinical Session
Chairs :
Constance Thibault (Hôpital Européen Georges Pompidou, Paris)
'Current clinical trials in prostate cancer'
Alice Bernard-Tessier (Institut Gustave Roussy, Paris)
'Targeting androgen receptor pathway for mCRPC: third-generation inhibitors'
Arnauld Villers (Hôpital Huriez, Lille)
'European Union recommendation in support of prostate cancer screening: what actions should be taken in the Member States?'
2:30 p.m
Coffee Break & Visit of Exhibition Booths
2:45 p.m.
Session IV : Organoids and Precision Medicine
Chairs :
Himisha Beltran (Dana-Farber Cancer Institute, Boston, MA, USA)
'Lineage plasticity as an emerging mechanism of resistance in prostate cancer'
Clémentine Le Magnen (University Hospital Basel, Switzerland)
'Patient-derived organoids to investigate drug response and drug resistance mechanisms in prostate cancer'
3:45 p.m.
Session V : Poster Session
Chairs : Edith Bonnelye & Jocelyn Ceraline
Les candidats au Prix du Meilleur Poster auront 3 minutes pour présenter leur poster/Candidates for the Best Poster Award will have 3 minutes to present their poster.
Seuls les étudiants de thèse et post-doctorants sont éligibles au prix du meilleur poster/Only thesis students and post-doctoral students are eligible for the best poster award.
5:15 p.m.
Session VI : 2021 ARTP Poster Prize Laureates
Chairs :
Luce Dreno (Inserm U981, IGR, Villejuif)
'Functional, structural and binding studies of the atypical er-resident protein fkbp7, a potential target in chemoresistant prostate cancer''
Despoina Pervizou (CIML, Marseille)
'Neutrophils: the immune cell population dominating murine prostate cancer'
5:30 p.m.
Assemblée Générale ARTP
Poster Prize Distribution
Alexandre de la Taille (Président), Olivier Cuvillier (Trésorier)
5:45 p.m.
End of the Meeting
Association Française d'Urologie, Pierre Fabre Médicament, Astellas, AstraZeneca, MSD